NYSE$HIMS
Hims & Hers Health Inc · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Reported outstanding Q2 2022 results driven by consumer-centric strategy and platform demand.
Hims & Hers Health, Inc. reported an 87% increase in quarterly revenue, reaching $113.6 million in Q2 2022. The company saw record growth in net new subscriptions for the second straight quarter, ending with 817,000 subscriptions. Due to this momentum, the company raised its full year 2022 revenue guidance to $470 million to $485 million and Adjusted EBITDA guidance to $(27) million to $(20) million.
- Revenue was $113.6 million for the second quarter 2022, an increase of 87% year-over-year.
- Net loss was $(19.7) million for the second quarter 2022.
- Gross margin was 77% for the second quarter 2022.
- Ended Q2 2022 with 817,000 subscriptions, up 80% year-over-year.
Headline financials
Revenue & EPS history
Hims & Hers · Revenue · Quarterly
$114M
Revenue by segment
Hims & Hers · $114M total across 2 segments · Q2 2022
- Online Revenue$107M+84.8%94.6%
- Wholesale Revenue$6.1M+139.6%5.4%
Forward guidance
Hims & Hers provides guidance based on current market conditions and expectations for revenue and Adjusted EBITDA. For the full year 2022, we expect revenue to be in the range of $470 million to $485 million and Adjusted EBITDA to be in the range of $(27) million to $(20) million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2022
+2.5%
Avg return
Earnings day
+3.8%
Avg return
5 days after
+11.7%
Avg return
30 days after
50%
13 / 26 earnings
Positive
+41.1%
Q4 2023
Best reaction
-22.3%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +3.0% | -11.4% | -1.8% | |
| Q4 2025 | -2.8% | -6.4% | +34.5% | |
| Q3 2025 | -3.6% | -7.6% | -9.8% | |
| Q1 2025 | +18.5% | +24.1% | +26.0% | |
| Q4 2024 | -22.3% | -12.1% | -37.8% | |
| Q3 2024 | +1.4% | +15.0% | +66.6% | |
| Q2 2024 | -4.0% | -9.2% | -16.9% | |
| Q1 2024 | +9.7% | +9.1% | +93.2% | |
| Q4 2023 | +41.1% | +37.8% | +65.3% | |
| Q3 2023 | +7.6% | +5.1% | +37.3% | |
| Q2 2023 | -8.7% | -11.7% | -15.2% | |
| Q1 2023 | -11.5% | -10.2% | -23.9% | |
| Q4 2022 | +15.4% | +6.0% | +2.7% | |
| Q3 2022 | +30.1% | +37.2% | +64.7% | |
| Q2 2022 | -3.4% | +9.2% | -0.6% | |
| Q1 2022 | -13.0% | -13.5% | +5.3% | |
| Q4 2021 | +8.0% | +20.5% | +19.8% | |
| Q3 2021 | -7.0% | -1.3% | -26.3% | |
| Q2 2021 | +7.0% | -4.7% | +11.1% | |
| Q1 2021 | +13.7% | +44.9% | +33.1% | |
| Q2 2020 | -8.4% | -7.2% | -21.9% | |
| Q4 2020 | -7.5% | -15.4% | -21.3% | |
| Q3 2020 | +0.1% | +0.0% | +17.5% | |
| Q1 2020 | -0.7% | -0.5% | +0.1% | |
| Q4 2019 | +1.4% | +2.1% | +2.2% | |
| Q3 2019 | +0.0% | +0.3% | -0.6% | |
| Q2 2019 | — | — | — | |
| Q1 2019 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro